ArticleObesity surgery2026
Ten-Year Outcomes of Single-Anastomosis Sleeve Ileal (SASI) Bypass: Surgical Configuration Determines Long-Term Efficacy and Safety.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe metabolic foundation of Single Anastomosis Sleeve Ileal (SASI) bypass is based on the combination of sleeve gastrectomy with a loop gastroileal bypass. The short- and mid-term outcomes were reported in favor of adequate weight loss and safe nutritional profile. The long-term efficacy and safety remain uncertain, particularly regarding optimal limb length and anastomosis size.
methodsA retrospective cohort study of patients who underwent SASI bypass between 2013 and 2014. Three groups based on the surgical technique: Group1: 2.5 m ileum, 4-6 cm anastomosis, Group2: 3.0 m ileum, 2.5 cm anastomosis, and Group3: 3.5 m ileum, 2.5 cm anastomosis. The primary outcome included weight loss, diabetic remission, and nutritional deficiencies requiring intervention.
resultsNinety-five patients were eligible with 10-year follow-up data available for 89 (93.7%). The mean percentage of excess weight loss (%EWL) was 58.6 ± 20.3%. Diabetic remission was sustained in 88%. Group1 had a 60% malnutrition rate and 40% reversal rate. Group2 and group3 showed significantly fewer nutritional complications, with no surgical revisions in Group 3. In this group, all diabetic patients remained in complete remission at 10 years. Weight outcomes between Groups 2 and 3 were comparable, though Group 3 had a slightly higher mean %EWL at 10 years (62.5% vs. 57.0%; p = 0.21).
conclusionSASI bypass offers durable long-term weight loss and diabetic remission rates at 10 years. Outcomes are highly dependent on surgical technique. The current data suggests the optimal outcome is offered with the 3.5 ileum/ 2.5 cm anastomosis configuration. Standardization of technique is critical to ensure long-term efficacy and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.